The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2019

Filed:

Dec. 19, 2014
Applicant:

Nitor Therapeutics, Birmingham, AL (US);

Inventor:

Shanta Bantia, Birmingham, AL (US);

Assignee:

Nitor Therapeutics, Birmingham, AL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/38 (2006.01); A61K 39/385 (2006.01); A61K 39/00 (2006.01); A61K 45/00 (2006.01); A61K 47/00 (2006.01); A61K 31/708 (2006.01); A61K 45/06 (2006.01); A61K 31/4745 (2006.01); A61K 31/675 (2006.01); A61K 31/7072 (2006.01); A61K 39/39 (2006.01); A61K 39/08 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 31/708 (2013.01); A61K 31/4745 (2013.01); A61K 31/675 (2013.01); A61K 31/7072 (2013.01); A61K 39/08 (2013.01); A61K 39/39 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55561 (2013.01);
Abstract

Methods and Compositions involving the administration of guanosine, identified as Toll like receptor (TLR) 2 and 4 agonists, that will be useful for enhancing the potency of vaccine and cancer immunotherapies are disclosed. Method of preventing and treating cancer and infection by administration of guanosine or pro-drugs of guanosine, or a precursor of guanosine are also disclosed. Compositions of guanosine or a pro-drug of guanosine or precursor of guanosine may be formulated as pharmaceutical dosage forms and components can be assembled as kits. Methods for activating TLRs with guanosine to enhance an immune response and to potentiate/augment antiviral, antibacterial or anticancer effects of other antiviral, anti-bacterial and anticancer therapeutic agents are also disclosed.


Find Patent Forward Citations

Loading…